Virios Therapeutics Inc (VIRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VIRI | AZN | AMGN | GILD | BMY |
| Company | Virios Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.2000 | 196.55 | 344.09 | 133.69 | 59.40 |
| High | 0.2068 | 196.65 | 347.68 | 134.07 | 59.70 |
| Low | 0.1430 | 194.80 | 342.97 | 131.34 | 58.68 |
| Latest | 0.1550 | 194.81 | 345.92 | 132.90 | 58.80 |
| Change | +0.0171 | -0.97 | +1.06 | -0.39 | -0.59 |
| % Change | +12.40% | -0.50% | +0.31% | -0.29% | -0.99% |
| Volume | 42,675,600 | 1,578,965 | 2,135,900 | 6,695,000 | 7,500,203 |
| 20-Day Average Volume | 2,719,065 | 1,869,055 | 2,438,195 | 5,246,050 | 9,626,505 |
| Previous Close | 0.1379 | 195.78 | 344.86 | 133.29 | 59.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1800 | 198.78 | 349.58 | 138.21 | 59.17 |
| 20-Day Raw Stochastic | 28.38% | 49.04% | 44.54% | 13.41% | 31.57% |
| 20-Day Relative Strength | 41.62 | 47.54 | 44.81 | 38.54 | 49.44 |
| Weighted Alpha | -74.16 | +37.39 | +21.80 | +24.66 | +26.33 |
| Today's Opinion | 100% Sell | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 64% Buy | 24% Buy | 24% Buy | 64% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.51% since 10/01/24 | -3.18% since 04/15/26 | -0.66% since 04/15/26 | -4.92% since 04/15/26 | +1.57% since 04/15/26 |
| Low | 0.1260 on 10/07/24 | 194.80 on 04/22/26 | 340.06 on 04/21/26 | 131.34 on 04/22/26 | 57.66 on 04/16/26 |
| High | 0.2068 on 10/08/24 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.26 on 04/16/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | -12.92% since 09/06/24 | +6.11% since 03/20/26 | -0.54% since 03/20/26 | -3.14% since 03/20/26 | +2.30% since 03/20/26 |
| Low | 0.1260 on 10/07/24 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.34 on 04/22/26 | 56.45 on 03/24/26 |
| High | 0.2282 on 09/17/24 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -39.22% since 07/08/24 | +6.23% since 01/22/26 | -0.33% since 01/22/26 | +1.34% since 01/22/26 | +7.03% since 01/22/26 |
| Low | 0.1260 on 10/07/24 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.00 on 01/23/26 | 54.21 on 01/29/26 |
| High | 0.3329 on 07/18/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -65.59% since 04/08/24 | +16.75% since 10/22/25 | +16.87% since 10/22/25 | +9.42% since 10/22/25 | +32.46% since 10/22/25 |
| Low | 0.1260 on 10/07/24 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.5292 on 04/15/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,985 | 303,636,768 | 186,115,760 | 165,442,480 | 121,258,640 |
| Shares Outstanding, K | 19,258 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -5,300,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -1,050,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.58 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/08/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/11/24 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.03 | 16.67 | 9.61 |